Form 4: CME Director Boosts Stake via Dividend Reinvestment

CME Group Inc. Director William R. Shepard increased his beneficial ownership of Class A Common Stock through a dividend reinvestment plan on December 30, 2025.

Summary

• William R. Shepard, a Director of CME Group Inc. (CME), acquired additional shares of Class A Common Stock.
• The transaction occurred on December 30, 2025, and involved the acquisition of shares through a dividend reinvestment plan administered by his broker.
• A direct acquisition of 11.06 shares of Class A Common Stock was made at a price of $278.37 per share.
• An indirect acquisition of 251.21 shares of Class A Common Stock was made by a Trust at a price of $278.37 per share.
• Following these transactions, William R. Shepard directly owns 2,477.39 shares of Class A Common Stock.
• Following these transactions, William R. Shepard indirectly owns 258,709.76 shares of Class A Common Stock through a Trust.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director's passive increase in ownership through a DRP indicates continued participation and confidence, though it's a routine event.

Positives

• A director increasing their beneficial ownership, even passively through a dividend reinvestment plan, can be viewed as a minor positive signal of continued confidence in the company's long-term prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitors.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership, even through a routine DRP, can be seen as a minor positive signal of alignment with shareholder interests.

Key Dates

Recommendation

The filing reports a routine insider transaction via a dividend reinvestment plan, which does not provide new information to alter an investment decision. It indicates a director's continued participation in the company's equity, which is generally a neutral to slightly positive signal but not a catalyst for a change in recommendation.

Keywords

CME Group, CME, Form 4, insider transaction, dividend reinvestment plan, beneficial ownership, director